Raltitrexed (Tomudex):: an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity

被引：62
作者：
Köhne, CH
Thuss-Patience, P
Friedrich, M
Daniel, PT
Kretzschmar, A
Benter, T
Bauer, B
Dietz, R
Dörken, B
机构：
[1] Humboldt Univ, Med Fak Charite, Virchow Klinikum,Robert Rossle Klin, Dept Haematol Oncol & Tumor Immunol, D-13125 Berlin, Germany
[2] Humboldt Univ, Med Fak Charite, Virchow Klinikum,Franz Volhard Klin, Dept Clin & Mol Cardiol, D-13125 Berlin, Germany
来源：
BRITISH JOURNAL OF CANCER | 1998年 / 77卷 / 06期
关键词：
5-fluorouracil; cardiotoxicity; raltitrexed; colorectal neoplasms;
D O I：
10.1038/bjc.1998.160
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Two patients with proven 5-fluorouracil (5-FU)-associated cardiotoxicity were treated with the specific thymidylate synthase inhibitor raltitrexed safely, without evidence of cardiotoxicity. Raltitrexed might be an alternative for patients with advanced colorectal cancer and 5-FU-associated cardiotoxicity. 5-FU cardiotoxicity is not due to the antineoplastic mechanisms via thymidilate synthase.
引用
收藏
页码：973 / 977
页数：5
相关论文
共 22 条
  • [1] AKHTAR SS, 1993, ONCOLOGY, V50, P441
  • [2] FLUOROURACIL CARDIOTOXICITY
    ANAND, AJ
    [J]. ANNALS OF PHARMACOTHERAPY, 1994, 28 (03) : 374 - 378
  • [3] 5-FLUOROURACIL-INDUCED CORONARY VASOSPASM
    BURGER, AJ
    MANNINO, S
    [J]. AMERICAN HEART JOURNAL, 1987, 114 (02) : 433 - 436
  • [4] COLLINS C, 1987, CANCER TREAT REP, V71, P733
  • [5] 'Tomudex' (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia
    Cunningham, D
    Zalcberg, JR
    Rath, U
    Olver, I
    VanCutsem, E
    Svensson, C
    Seitz, JF
    Harper, P
    Kerr, D
    PerezManga, G
    Azab, M
    Seymour, L
    Lowery, K
    Ackland, SP
    Basser, RL
    Clarke, SJ
    Goldstein, D
    Green, MD
    Grygiel, JJ
    McKendrick, JJ
    Millward, MJ
    Olver, IN
    Tattersall, MHN
    Thomson, DB
    Jakesz, R
    Buset, M
    Tueni, EA
    VanCutsem, EJD
    Bauer, J
    Beska, F
    Adenis, A
    Brunet, R
    Francois, E
    Paillot, B
    Rougier, P
    Fink, UFW
    Knuth, KRA
    Koenig, HJ
    Bohme, MWJ
    Wander, HE
    Amadori, D
    Frassineti, L
    Cocconi, G
    Passalacqua, R
    Frigerio, F
    Barni, S
    Luporini, G
    Labianca, R
    Marini, G
    Zaniboni, A
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A (12) : 1945 - 1954
  • [6] DENT RG, 1975, LANCET, V1, P347
  • [7] GAMELIN E, 1991, B CANCER, V78, P1147
  • [8] EXPECTANCY OR PRIMARY CHEMOTHERAPY IN PATIENTS WITH ADVANCED ASYMPTOMATIC COLORECTAL-CANCER - A RANDOMIZED TRIAL
    GLIMELIUS, B
    PAHLMAN, L
    GRAF, W
    ADAMI, HO
    TVEIT, K
    HANSEN, J
    LILJEGREN, G
    DOMELoF, L
    LJUNGQVIST, U
    BERGMAN, L
    ENANDER, LK
    UNDERSKOG, I
    SoDERBERG, M
    JoNSSON, PE
    HAFSTRoM, L
    HEUMAN, R
    ATHLIN, L
    SASSNER, P
    SELLSTRoM, H
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (06) : 904 - 911
  • [9] Harper P, 1997, P AN M AM SOC CLIN, V16, p228a
  • [10] CARDIAC TOXICITY OF 5-FLUOROURACIL - A STUDY ON 1083 PATIENTS
    LABIANCA, R
    BERETTA, G
    CLERICI, M
    FRASCHINI, P
    LUPORINI, G
    [J]. TUMORI, 1982, 68 (06) : 505 - 510
123